文献速递肝肾功能剂量调整特殊人群用药抗栓抗凝管理

阿哌沙班抗Xa因子水平在临床实践中的应用:一例病例报告

Apixaban anti-Xa levels in clinical practice: A case report.
PubMed 文献 · Br J Clin Pharmacol · 2024-09-16

本文报告一例老年慢性肾脏病患者的病例:该患者因急性肺栓塞服用阿哌沙班,意外出现半衰期延长,末次给药后超过10天仍可检测到阿哌沙班校准的抗Xa因子水平,导致必要的手术干预延迟超过1周。本病例展示了在围手术期规划中合理使用阿哌沙班校准的抗Xa因子水平来指导治疗决策。

要点

  • 阿哌沙班长期使用无需常规实验室监测,但特定情况下抗Xa因子检测有临床价值。
  • 肾功能不全、依从性评估、围手术期规划、极端体重和高龄时可用抗Xa因子检测。
  • 本例老年CKD患者阿哌沙班半衰期延长,末次给药后>10天仍可检测到抗Xa水平。

核心结论

  • 阿哌沙班校准的抗Xa因子检测可用于围手术期规划,指导治疗决策。

研究设计与样本

  • 病例报告:一例老年慢性肾脏病患者因急性肺栓塞服用阿哌沙班。

主要发现

  • 患者阿哌沙班半衰期意外延长,末次给药后>10天仍可检测到阿哌沙班校准的抗Xa因子水平。
  • 检测结果导致必要的手术干预延迟>1周。

关键数值与推荐

  • 房颤患者推荐减量的条件:高龄(≥80岁)、低体重(≤60 kg)或血清肌酐升高(≥1.5 mg/dL)。
  • 治疗急性静脉血栓栓塞时,不推荐因肾功能不全而减少阿哌沙班剂量。

临床怎么用

  • 在肾功能不全、依从性评估、围手术期规划、极端体重和高龄等特定情况下,可考虑使用阿哌沙班校准的抗Xa因子检测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Apixaban is a widely used direct oral anticoagulant that is recommended over warfarin therapy for many clinical indications. In patients with atrial fibrillation, dose reductions are recommended for patients with advanced age (≥80 years), low weight (≤60 kg) or elevated serum creatinine (≥1.5 mg/dL), but there is no routine laboratory monitoring necessary for long term-use. Furthermore, apixaban dose reductions due to renal dysfunction are not recommended when treating acute venous thromboembolism. Apixaban-calibrated anti-Xa assays are readily available at some medical centres, and they may be of clinical utility in certain circumstances such as in patients with renal insufficiency, medication adherence assessment, periprocedural planning, extremes in body weight and advanced age. Here, we describe the case of an elderly patient with chronic kidney disease taking apixaban for acute pulmonary embolism. The patient had an unanticipated prolonged apixaban half-life, with detectable apixaban-calibrated anti-Xa levels for >10 days after the last administered dose, which delayed a necessary surgical intervention by >1 week. This case is an example of appropriately using apixaban-calibrated anti-Xa levels to guide therapeutic decision making in perioperative planning.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Clark S, Alcala-Zermeno JL. Apixaban anti-Xa levels in clinical practice: A case report. Br J Clin Pharmacol. 2024. PMID: 39285695. doi:10.1111/bcp.16247

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。